ST-Elevation MI — ED to Reperfusion

Key Points

• STEMI is a reperfusion diagnosis; do not wait for troponin when the ECG and clinical picture are diagnostic.
• Primary PCI is preferred when it can be delivered within an efficient regional system.
• Fibrinolysis is reserved for eligible early presenters when timely PCI is not available and must be followed by transfer to a PCI-capable center.
• Screen carefully for aortic dissection and fibrinolysis contraindications before giving lytic therapy.
• Aspirin, a P2Y12 inhibitor, anticoagulation, and high-intensity statin therapy are core components of care.
• Routine oxygen is not indicated when oxygen saturation is normal.
• Radial access is preferred for PCI when feasible because of lower bleeding risk.
• Shock, recurrent ischemia, failed fibrinolysis, or malignant arrhythmia requires immediate escalation and invasive management.

Algorithm

1. Recognize ischemic symptoms and obtain a 12-lead ECG within 10 minutes.
2. Confirm STEMI or an occlusion-equivalent pattern, assess hemodynamics, and exclude obvious contraindicating diagnoses such as aortic dissection.
3. Activate the PCI system immediately; do not wait for biomarkers.
4. Give aspirin and guideline-directed additional antiplatelet and anticoagulant therapy.
5. If PCI cannot be delivered within acceptable system delay and the patient is an eligible early presenter, give fibrinolysis and arrange immediate transfer.
6. Assess reperfusion after lysis; perform rescue PCI for failed reperfusion or instability.
7. Monitor for arrhythmia, heart failure, shock, mechanical complications, recurrent ischemia, and bleeding.
8. Before discharge, initiate secondary prevention and cardiac rehabilitation and document antiplatelet duration.

Clinical Synopsis & Reasoning

Obtain a 12-lead ECG within 10 minutes of first medical contact or emergency arrival for concerning ischemic symptoms. STEMI can present with pressure, dyspnea, diaphoresis, nausea, epigastric discomfort, syncope, or atypical symptoms. Identify contiguous ST elevation according to age-, sex-, and lead-specific criteria, but also recognize posterior infarction, right ventricular infarction, and other occlusion patterns that may not fit classic criteria. Repeat ECGs when symptoms persist and the first tracing is nondiagnostic. Do not delay reperfusion for troponin when the ECG and clinical syndrome establish STEMI. Examine for shock, pulmonary edema, new murmur, mechanical complications, and signs of aortic dissection because antithrombotic or fibrinolytic therapy can be catastrophic in dissection. Right-sided leads are useful with inferior infarction and hypotension; posterior leads help when reciprocal anterior ST depression suggests posterior occlusion. Bedside echocardiography can clarify shock or uncertain diagnosis but should not postpone transfer to the catheterization laboratory. Cardiogenic shock, recurrent ventricular arrhythmia, and cardiac arrest markedly increase risk and require coordinated critical care.

Treatment Strategy & Disposition

Activate primary PCI immediately when the patient is at or can be transferred to a PCI-capable center within guideline-supported system delays. Radial arterial access is preferred for PCI when feasible because it reduces bleeding and vascular complications. Give aspirin promptly and add a P2Y12 inhibitor selected for the reperfusion strategy and bleeding risk. Provide procedural anticoagulation according to the PCI or fibrinolysis pathway. If timely PCI cannot be achieved, symptom onset is generally within 12 hours, and no contraindication exists, fibrinolytic therapy is an option, followed by immediate transfer to a PCI center for a pharmacoinvasive strategy. Failed reperfusion, recurrent ischemia, shock, or instability after lysis requires rescue PCI. Use nitroglycerin for ongoing ischemia or hypertension when blood pressure and infarct location allow; avoid it in hypotension, right ventricular infarction with preload dependence, or recent phosphodiesterase-5 inhibitor use. Do not give routine oxygen to normoxemic patients. Start high-intensity statin therapy and evidence-based secondary prevention. In cardiogenic shock, emergent revascularization of the culprit vessel is central; routine immediate multivessel PCI in shock is generally avoided unless anatomy or circumstances require it.

Epidemiology / Risk Factors

• STEMI represents a major subset of acute coronary syndromes and remains time-sensitive despite falling mortality in mature reperfusion systems.
• Atherosclerotic plaque rupture with thrombotic coronary occlusion is the most common mechanism.
• Smoking, hypertension, dyslipidemia, diabetes, chronic kidney disease, and established vascular disease are major risk factors.
• Delays are more common in patients with atypical symptoms, older age, and limited access to PCI-capable systems.
• Regional STEMI networks improve outcomes by coordinating prehospital ECG, direct catheterization-laboratory activation, and interfacility transfer.

Investigations

Reperfusion Strategy (Adult)

Pharmacology

Prognosis / Complications

• Mortality rises with increasing ischemic time, cardiogenic shock, anterior infarction, cardiac arrest, older age, kidney disease, and reduced ventricular function.
• Successful early reperfusion limits infarct size and reduces heart failure and death.
• Arrhythmias and mechanical complications are concentrated in the early phase but remodeling and heart failure can develop later.
• Bleeding risk from antithrombotic and reperfusion therapy must be managed without withholding lifesaving reperfusion when benefit clearly exceeds risk.
• Long-term prognosis improves with smoking cessation, lipid lowering, cardiac rehabilitation, medication adherence, and control of blood pressure and diabetes.

Patient Education / Counseling

• Explain that the blocked coronary artery was treated as rapidly as possible because heart-muscle loss increases with delay.
• After stenting, emphasize that stopping antiplatelet medication without specialist advice can cause life-threatening stent thrombosis.
• Review emergency symptoms including recurrent chest pressure, dyspnea, syncope, or palpitations.
• Encourage participation in cardiac rehabilitation and establish a plan for smoking cessation, activity progression, diet, blood pressure, and lipid management.
• Discuss return to driving, work, and sexual activity using individualized cardiology guidance rather than a single universal timeline.

Notes

STEMI management is defined by speed with discrimination. The team must move fast enough to restore coronary flow while still recognizing the uncommon conditions in which antithrombotic or fibrinolytic therapy would be dangerous. Primary PCI is the preferred reperfusion method in an effective regional system; fibrinolysis remains important when PCI delay is excessive and the patient is eligible. After the artery is opened, attention shifts to shock, arrhythmia, mechanical complications, bleeding prevention, ventricular function, and durable secondary prevention.

References

1. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes — Link